BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 15007346)

  • 1. Airway peptidoglycan and immunostimulatory DNA exposures have divergent effects on the development of airway allergen hypersensitivities.
    Chisholm D; Libet L; Hayashi T; Horner AA
    J Allergy Clin Immunol; 2004 Mar; 113(3):448-54. PubMed ID: 15007346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccinations with T-helper type 1 directing adjuvants have different suppressive effects on the development of allergen-induced T-helper type 2 responses.
    Trujillo-Vargas CM; Mayer KD; Bickert T; Palmetshofer A; Grunewald S; Ramirez-Pineda JR; Polte T; Hansen G; Wohlleben G; Erb KJ
    Clin Exp Allergy; 2005 Aug; 35(8):1003-13. PubMed ID: 16120081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modification of allergic inflammation in murine model of rhinitis by different bacterial ligands: involvement of mast cells and dendritic cells.
    Yamamoto K; Kawamura I; Ito J; Mitsuyama M
    Clin Exp Allergy; 2006 Jun; 36(6):760-9. PubMed ID: 16776677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. House dust extracts have both TH2 adjuvant and tolerogenic activities.
    Ng N; Lam D; Paulus P; Batzer G; Horner AA
    J Allergy Clin Immunol; 2006 May; 117(5):1074-81. PubMed ID: 16675335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toll-like receptor-2 agonist-allergen coupling efficiently redirects Th2 cell responses and inhibits allergic airway eosinophilia.
    Krishnaswamy JK; Jirmo AC; Baru AM; Ebensen T; Guzmán CA; Sparwasser T; Behrens GM
    Am J Respir Cell Mol Biol; 2012 Dec; 47(6):852-63. PubMed ID: 22962064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mice vaccinated with allergen-pulsed myeloid dendritic cells are not protected from developing allergen-induced Th2 responses.
    Trujillo-Vargas CM; Ramirez-Pineda JR; Palmetshofer A; Grunewald S; Moll H; Berberich C; Erb KJ
    Int Arch Allergy Immunol; 2005 Jul; 137(3):219-28. PubMed ID: 15956790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toll-like receptor 4 agonists adsorbed to aluminium hydroxide adjuvant attenuate ovalbumin-specific allergic airway disease: role of MyD88 adaptor molecule and interleukin-12/interferon-gamma axis.
    Bortolatto J; Borducchi E; Rodriguez D; Keller AC; Faquim-Mauro E; Bortoluci KR; Mucida D; Gomes E; Christ A; Schnyder-Candrian S; Schnyder B; Ryffel B; Russo M
    Clin Exp Allergy; 2008 Oct; 38(10):1668-79. PubMed ID: 18631348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunostimulatory sequence oligdeoxynucleotide/cholera toxin B conjugate: a novel allergen-independent intranasal vaccine for allergic rhinitis.
    Won TB; Quan SH; Kim DY; Rhee CS; Lee CH
    Ann Allergy Asthma Immunol; 2009 Apr; 102(4):314-22. PubMed ID: 19441603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allergen-independent immunostimulatory sequence oligodeoxynucleotide therapy attenuates experimental allergic rhinitis.
    Rhee CS; Libet L; Chisholm D; Takabayashi K; Baird S; Bigby TD; Lee CH; Horner AA; Raz E
    Immunology; 2004 Sep; 113(1):106-13. PubMed ID: 15312141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of sublingual administration with a native or denatured protein allergen and adjuvant CpG oligodeoxynucleotides or cholera toxin on systemic T(H)2 immune responses and mucosal immunity in mice.
    Huang CF; Wang CC; Wu TC; Chu CH; Peng HJ
    Ann Allergy Asthma Immunol; 2007 Nov; 99(5):443-52. PubMed ID: 18051215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allergic sensitization is enhanced in early life through toll-like receptor 7 activation.
    Phipps S; Hansbro N; Lam CE; Foo SY; Matthaei KI; Foster PS
    Clin Exp Allergy; 2009 Dec; 39(12):1920-8. PubMed ID: 19735273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunostimulatory DNA inhibits allergen-induced peribronchial angiogenesis in mice.
    Lee SY; Cho JY; Miller M; McElwain K; McElwain S; Sriramarao P; Raz E; Broide DH
    J Allergy Clin Immunol; 2006 Mar; 117(3):597-603. PubMed ID: 16522459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunostimulatory DNA sequences inhibit IL-5, eosinophilic inflammation, and airway hyperresponsiveness in mice.
    Broide D; Schwarze J; Tighe H; Gifford T; Nguyen MD; Malek S; Van Uden J; Martin-Orozco E; Gelfand EW; Raz E
    J Immunol; 1998 Dec; 161(12):7054-62. PubMed ID: 9862743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Orally administered OVA/CpG-ODN induces specific mucosal and systemic immune response in young and aged mice.
    Alignani D; Maletto B; Liscovsky M; Rópolo A; Morón G; Pistoresi-Palencia MC
    J Leukoc Biol; 2005 Jun; 77(6):898-905. PubMed ID: 15758079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunostimulatory oligonucleotides block allergic airway inflammation by inhibiting Th2 cell activation and IgE-mediated cytokine induction.
    Hessel EM; Chu M; Lizcano JO; Chang B; Herman N; Kell SA; Wills-Karp M; Coffman RL
    J Exp Med; 2005 Dec; 202(11):1563-73. PubMed ID: 16314434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TLR7 imidazoquinoline ligand 3M-019 is a potent adjuvant for pure protein prototype vaccines.
    Johnston D; Zaidi B; Bystryn JC
    Cancer Immunol Immunother; 2007 Aug; 56(8):1133-41. PubMed ID: 17139492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental gastrointestinal allergy enhances pulmonary responses to specific and unrelated allergens.
    Brandt EB; Scribner TA; Akei HS; Rothenberg ME
    J Allergy Clin Immunol; 2006 Aug; 118(2):420-7. PubMed ID: 16890767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of ovalbumin-induced Th2 responses by second-generation immunomodulatory oligonucleotides in mice.
    Zhu FG; Kandimalla ER; Yu D; Tang JX; Agrawal S
    Int Immunopharmacol; 2004 Jul; 4(7):851-62. PubMed ID: 15182725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunostimulatory oligodeoxynucleotide from Bifidobacterium longum suppresses Th2 immune responses in a murine model.
    Takahashi N; Kitazawa H; Iwabuchi N; Xiao JZ; Miyaji K; Iwatsuki K; Saito T
    Clin Exp Immunol; 2006 Jul; 145(1):130-8. PubMed ID: 16792683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccination with recombinant fusion proteins incorporating Toll-like receptor ligands induces rapid cellular and humoral immunity.
    Huleatt JW; Jacobs AR; Tang J; Desai P; Kopp EB; Huang Y; Song L; Nakaar V; Powell TJ
    Vaccine; 2007 Jan; 25(4):763-75. PubMed ID: 16968658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.